Nektar Therapeutics (NKTR) short interest & options flow
NASDAQNektar Therapeutics has clawed back 5% over the past week to $60.55. Short sellers have been cutting positions. But the options market tells a different story. Why this matters: Three distinct signals are now pointing in conflicting directions on NKTR. Shorts are covering, but put buyers are growing more active. The borrow market remains loose. The divergence, set against an…
NKTR cost to borrow surges 586% in one week to 0.46%, though absolute rate stays minimal.
- Market cap
- $1.27B
- Next earnings
- 11 Nov 2026
Key data as of 7 Nov 2026

Latest signals on NKTR
- Cost to Borrow
NKTR cost to borrow surges 586% in one week to 0.46%, though absolute rate stays minimal.
NKTR news and analysis
RSSNo long-form analysis yet for NKTR. Pulse alerts and the live data picture are available on ORTEX.
Open NKTR on ORTEX →Want the live picture for NKTR?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NKTR — free to start on ORTEX.
Sign up for free →Open NKTR on ORTEX